Caxton Associates (New York)’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,813
Closed -$284K – 687
2022
Q1
$284K Sell
4,813
-1,798
-27% -$102K 0.02% 371
2021
Q4
$380K Buy
6,611
+1,831
+38% +$101K 0.04% 343
2021
Q3
$256K Buy
+4,780
New +$299K 0.03% 354
2019
Q4
– Sell
-5,292
Closed -$436K – 506
2019
Q3
$436K Sell
5,292
-1,807
-25% -$147K 0.09% 157
2019
Q2
$554K Hold
7,099
– – 0.07% 178
2019
Q1
$558K Buy
+7,099
New +$564K 0.08% 129

Other funds holding NHI

Caxton Associates (New York)'s NHI Position: Q2 2022 in Review

Caxton Associates (New York) sold out of National Health Investors (NHI) in Q2 2022, closing a stake of 4,813 shares — an estimated $284K sold.

Caxton Associates (New York) first reported a position in NHI in Q1 2019 and held it in 6 quarters. The position peaked at $558K in Q1 2019. 235 funds tracked by Wall St. Rank hold NHI as of Q2 2022.

  • Caxton Associates (New York) reported no remaining National Health Investors position as of Q2 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,813 National Health Investors shares in Q2 2022, an estimated $284K.
  • Caxton Associates (New York) first reported a position in National Health Investors in Q1 2019 and held it in 6 quarters.
  • Caxton Associates (New York)'s National Health Investors position peaked at $558K in Q1 2019.
  • 235 funds tracked by Wall St. Rank held National Health Investors as of Q2 2022.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.